Re: The correlation between PD-L1 expression and metabolic parameters of 18FDG PET/CT and the prognostic value of PD-L1 in non-small cell lung cancer

被引：0
|
作者：
Huang, Mouqing [1 ]
Guo, Jia [1 ]
机构：
[1] Ganzhou Peoples Hosp, Nucl Med Dept, Ganzhou 341000, Jiangxi, Peoples R China
来源：
CLINICAL IMAGING | 2023年 / 93卷
关键词：
PD-L1 expression and 18FDG PET/CT; RESECTION;
D O I：
10.1016/j.clinimag.2022.08.008
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
We read with great interest the recent study conducted by Xu et al1. In this study, the authors investigated the correlation of programmed death ligand-1 (PD-L1) expression with metabolic parameters measured by F-18-fluorodeoxyglucose positron emission computed tomography (F-18-FDG PET/CT) and its prognostic value in patients with surgically resected non-small-cell lung cancer (NSCLC). The results of this study1 found that in NSCLC patients, the maximum standardized uptake value (SUVmax) measured by F-18-FDG PET/CT was a predictor of PD-L1 expression, and both PD-L1 and TLG were prognostic factors for the prognosis of NSCLC patient. Undoubtedly, the novel findings of this study help to further refine the risk stratification of NSCLC patients. However, after reading this article carefully, we would like to share the following points.
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
  • [21] The predictive value of total-body PET/CT in non-small cell lung cancer for the PD-L1 high expression
    Hu, B.
    Jin, H.
    Li, X.
    Wu, X.
    Xu, J.
    Gao, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S378 - S379
  • [22] The predictive value of total-body PET/CT in non-small cell lung cancer for the PD-L1 high expression
    Hu, Bingxin
    Jin, Huibin
    Li, Xiali
    Wu, Xinyu
    Xu, Junling
    Gao, Yongju
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Polymorphisms of the PD-L1 gene 3′-untranslated region are associated with the expression of PD-L1 in non-small cell lung cancer
    Ohhara, Yoshihito
    Tomaru, Utano
    Kinoshita, Ichiro
    Hatanaka, Kanako C.
    Noguchi, Takuro
    Hatanaka, Yutaka
    Amono, Toraji
    Matsuno, Yoshihiro
    Dosaka-Akita, Hirotoshi
    GENES CHROMOSOMES & CANCER, 2024, 63 (01):
  • [24] The prognostic value of PD-L1 expression for non-small cell lung cancer patients: A meta-analysis
    Wang, A.
    Wang, H. Y.
    Liu, Y.
    Zhao, M. C.
    Zhang, H. J.
    Lu, Z. Y.
    Fang, Y. C.
    Chen, X. F.
    Liu, G. T.
    EJSO, 2015, 41 (04): : 450 - 456
  • [25] PD-L1 expression in different samples of non-small cell lung cancer
    Kovacevic, M.
    Kern, I.
    VIRCHOWS ARCHIV, 2017, 471 : S104 - S104
  • [26] Predicting PD-L1 expression using [18F]FDG PET/CT in early stage non-small cell lung cancer (NSCLC)
    Hughes, D. J.
    Josephides, E.
    O'Shea, R.
    Manickavasagar, T.
    Horst, C.
    Hunter, S.
    Taniere, P.
    Nonaka, D.
    Spicer, J.
    Goh, V.
    Bille, A.
    Karapanagiotou, E. M.
    Cook, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S741 - S741
  • [27] PD-L1 Expression and Molecular Alterations in Non-Small Cell Lung Cancer
    Ebare, K.
    Song, W.
    Opitz, L.
    Rosca, O.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S52 - S53
  • [28] PD-L1 expression: An emerging biomarker in non-small cell lung cancer
    Adam, Julien
    Planchard, David
    Marabelle, Aurelien
    Soria, Jean-Charles
    Scoazec, Jean-Yves
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2016, 36 (01) : 94 - 102
  • [29] Predicting PD-L1 expression status in patients with non-small cell lung cancer using [18F]FDG PET/CT radiomics
    Zhao, Xiaoqian
    Zhao, Yan
    Zhang, Jingmian
    Zhang, Zhaoqi
    Liu, Lihua
    Zhao, Xinming
    EJNMMI RESEARCH, 2023, 13 (01)
  • [30] PD-L1 expression is associated with advanced non-small cell lung cancer
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Wang, Guochen
    Li, Zuosheng
    Hou, Jingpu
    Zhang, Qiuyang
    You, Zongbing
    Zhang, Liu
    ONCOLOGY LETTERS, 2016, 12 (02) : 921 - 927
12345